SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-009126
Filing Date
2018-04-02
Accepted
2018-04-02 20:18:21
Documents
2
Period of Report
2018-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1674
2 EX-24 DOCUMENT attachment1.htm EX-24 4390
  Complete submission text file 0000899243-18-009126.txt   7629
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Issuer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
BEIER DAVID W (Reporting) CIK: 0001187054 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-31141 | Film No.: 18731019